NCT05179083

Brief Summary

Nearly 100 million Americans are affected by neurological disorders with an overall cost above $765 billion for the more prevalent conditions. Given this significant burden, effective treatments to prevent dementia and new disease modifying therapies are urgently needed. Regeneration of lost neurons with new ones (i.e., neurogenesis) is compromised at early stages of dementia and in part correlates with cognitive impairment in Alzheimer's disease. Boosting the neurogenesis delays the cognitive impairment in animal models of dementia and has been proven beneficial in improving the memory in rodent studies. Aerobic exercise is the most potent known stimulator of neurogenesis in animal models. A crucial next step is to translate endogenous regenerative strategies to people. The purpose of this study is to demonstrate the feasibility and investigate the effects of an exercise program on neurogenesis and cognitive improvement in epilepsy patients.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10

participants targeted

Target at below P25 for phase_1

Timeline
Completed

Started Aug 2022

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 30, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 5, 2022

Completed
8 months until next milestone

Study Start

First participant enrolled

August 20, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 31, 2024

Completed
Last Updated

December 6, 2023

Status Verified

December 1, 2023

Enrollment Period

2 years

First QC Date

November 30, 2021

Last Update Submit

December 5, 2023

Conditions

Keywords

ExerciseNeurogenesisMesial temporal lobe epilepsyRegenerationCognitionElectrophysiology

Outcome Measures

Primary Outcomes (1)

  • Adherence to exercise and assessments

    Number of completed exercise and assessment sessions

    Through study completion, an average of 6 months

Secondary Outcomes (5)

  • Neurogenesis

    13 weeks after first exercise session

  • Rey Auditory Verbal Learning Test (RAVLT) - Trial V

    Baseline and 12 weeks after first exercise session

  • Rey Auditory Verbal Learning Test (RAVLT) - Summary score

    Baseline and 12 weeks after first exercise session

  • WAIS-IV - Matrix Reasoning

    Baseline and 12 weeks after first exercise session

  • Rey Complex Figure Test (RCFT)

    Baseline and 12 weeks after first exercise session

Study Arms (2)

High-impact Exercise

EXPERIMENTAL
Other: High-Impact Aerobic Exercise

Low-impact Exercise

ACTIVE COMPARATOR
Other: Low-Impact Aerobic Exercise

Interventions

Participants will be submitted to a 12-week high-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (80% of maximum) is reached, followed by 10 minutes of cool down.

High-impact Exercise

Participants will be submitted to a 12-week low-impact aerobic exercise program using a recliner bike with three sessions per week. The exercise protocol takes 45 minutes per session and consists of five minutes of warm-up, 30 minutes of cycling with progressive increase in intensity until the target heart rate (40% of maximum) is reached, followed by 10 minutes of cool down.

Low-impact Exercise

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age of 18 years or older
  • Medically resistant mesial temporal lobe epilepsy
  • Candidacy for standard or selective temporal lobectomy

You may not qualify if:

  • Age of older than 65 years
  • Pregnancy
  • Physical disabilities or medical conditions preventing from participation in exercise program
  • Inability to receive exercise equipment at home
  • Cognitive/developmental disabilities restricting the participation in exercise program

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Southern California Department of Neurosurgery

Los Angeles, California, 90033, United States

RECRUITING

Related Publications (1)

  • Gooch CL, Pracht E, Borenstein AR. The burden of neurological disease in the United States: A summary report and call to action. Ann Neurol. 2017 Apr;81(4):479-484. doi: 10.1002/ana.24897. No abstract available.

    PMID: 28198092BACKGROUND

MeSH Terms

Conditions

Epilepsy, Temporal LobeMotor Activity

Condition Hierarchy (Ancestors)

Epilepsies, PartialEpilepsyBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesEpileptic SyndromesBehavior

Study Officials

  • Jonathan J Russin, MD

    University of Southern California

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Jonathan J Russin, MD

CONTACT

Study Design

Study Type
interventional
Phase
phase 1
Allocation
RANDOMIZED
Masking
QUADRUPLE
Who Masked
PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor of Clinical Neurological Surgery

Study Record Dates

First Submitted

November 30, 2021

First Posted

January 5, 2022

Study Start

August 20, 2022

Primary Completion

August 31, 2024

Study Completion

August 31, 2024

Last Updated

December 6, 2023

Record last verified: 2023-12

Data Sharing

IPD Sharing
Will not share

Locations